Modulation of melanoma cell phospholipid metabolism in response to heat shock protein 90 inhibitionMounia Beloueche‐Babari, Martin O. Leach|Oncotarget|2010Cited by 23
Acute tumour response to the MEK1/2 inhibitor selumetinib (AZD6244, ARRY-142886) evaluated by non-invasive diffusion-weighted MRIMounia Beloueche‐Babari, Simon P. Robinson|British Journal of Cancer|2013Cited by 23
Detecting human melanoma cell re-differentiation following BRAF or heat shock protein 90 inhibition using photoacoustic and magnetic resonance imagingAnant Shah, Mounia Beloueche‐Babari|Scientific Reports|2017Cited by 14